Peptide record

TPDB03378

Antibacterial Hemolysis Toxicity standard
26 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB03378
Antibacterial Hemolysis Toxicity
Anti-infective peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia HemoPI Hemolytic2 PD_Hemolysis
standard
No
A 26-aa standard natural multi-activity (Antibacterial, Hemolysis, and Toxicity) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
KWKSFLKTFKSLKKTVLHTALKLISS
Physicochemical Analysis
C145H242N36O34
RNDCEQGMPY
K
3033.74
11.29
8
0
11
+7
1.51
-0.062
105.00
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
5500
181.29
7
Residue Composition
number
1
A
0
R
0
N
0
D
0
C
0
E
0
Q
0
G
1
H
1
I
5
L
7
K
0
M
2
F
0
P
4
S
3
T
1
W
0
Y
1
V
Amino Acid Distribution
A: 1 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 1 I: 1 L: 5 K: 7 M: 0 F: 2 P: 0 S: 4 T: 3 W: 1 Y: 0 V: 1
Chemical Descriptors
26
C145H242N36O34
3033.74
11.29
+7
1.51
-0.062
Evidence Records 4 records
Evidence 1 Activity

Activity

MHC
Hemolysis
15.6 µg/mL
[Ref.17158938]MHC=15.6 µg/ml against human red blood cells

Target

human red blood cells

Source & Reference

Hemolytik PD_Hemolysis
DRAMP4
Antimicrob Agents Chemother. 2007 Apr 51(4):1398-406.

Other

Source Activity Label Source Definition
Hemolysis
Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 2 Activity

Activity

0% Hemolysis
Toxicity
15.6 µg/mL
Hemolytic Cytotoxic
0% Hemolysis | 15.6 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides | Antimicrob Agents Chemother | 2007
Evidence 3 Activity

Activity

MHC
Toxicity
15.6 µg/mL
Hemolytic
Hemolytic_activity: [Ref.17158938]MHC=15.6 µg/ml against human red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
Antimicrob Agents Chemother. 2007 Apr 51(4):1398-406.
Evidence 4 Hemolysis

Activity

15.6 µg/mL
MHC
[Ref.17158938]MHC=15.6 µg/ml against human red blood cells
Hemolysis

Target

human red blood cells

Source & Reference

HemoPI PD_Hemolysis
Antimicrob Agents Chemother. 2007 Apr 51(4):1398-406.
DRAMP4
PD_Hemolysis